GBS supports preclinical and clinical studies evaluating the safety and efficacy of monoclonal antibodies and therapeutic compounds as well as in custom-development of cell-based platforms for mode-of action or proof of principle studies.
Our core services focus on Hemostasis and Thrombosis, Immunobiology, Cellular Bioenergetics and Neurodegeneration.
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_1.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_2.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_3.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_4.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_5-1.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_6.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_7.png)
![](http://gbsleiden.com/wp-content/uploads/2017/06/Screenshot_8.png)